期刊文献+

黑龙江省WHO结核病耐药监测报告 被引量:18

WHO TB drug resistant survey in Heilongjiang province
下载PDF
导出
摘要 目的掌握黑龙江省结核病细菌学耐药水平,评价结核病控制质量和效果,为制定全省结核病防治规划提供依据。方法采用分层整群抽样,选取30个县(区)作为监测点,每个监测点痰涂片抗酸染色检查为阳性的病人均为入选病例,初治涂阳病人入选56例。采用比例法对INH、SM、RFP、EMB进行药物敏感性试验。结果2004年耐药监测期间总纳入病例2144例,其中,痰培养污染率2.1%、涂阳培阴率3.8%,进行药敏试验人数2019例,供药敏分析1995例,初治病人占78.9%、复治病人占21.1%。初始耐药率为36.2%,获得性耐药率为67.7%,初始MDR耐药率为7.2%,获得性MDR耐药率为30.4%。结论黑龙江省结核病耐药水平是已知开展耐药监测省份中高耐药省份之一,对黑龙江省结核病控制工作带来严重挑战。提示黑龙江省要一方面进一步提高全省DOTS的实施质量,通过做好基本DOTS来逐步减少耐药结核病人的产生;另一方面要积极争取解决现有耐药结核病人的治疗问题,最大限度地减少耐药结核病例,如期实现结防规划目标。 Objective To understand the status of drug resistant in M. tuberculosis in Heilongjiang province, to evaluate the quality and effectiveness of TB control and provide evidence for TB control policy development in Heilongjiang province. Methods According to the Guidelines for Surveillance of Drug Resistance in Tuberculosis of WHO/IUATLD, sampling method of layered group, thirty counties/districts were selected as surveillance sites. All smear positive cases on each surveillance site were included in the surve...
出处 《中国防痨杂志》 CAS 2008年第5期395-398,共4页 Chinese Journal of Antituberculosis
关键词 结核 耐药 监测 黑龙江省 tuberculosis drug resistance survey Heilongjiang province
  • 相关文献

参考文献7

二级参考文献21

  • 1梅建,薛桢,沈鑫,沈国妙,桂晓红,沈梅,高谦.原发性耐药是耐药结核病产生的重要原因[J].中华结核和呼吸杂志,2006,29(2):75-78. 被引量:103
  • 2端木宏谨.耐药结核病的流行和监测[J].中华结核和呼吸杂志,2006,29(8):509-511. 被引量:38
  • 3[1]World Health Organization/International Union Against Tuberculosis and Lung Diseases.Guidelines for surveillance of drug resistance in tuberculosis.Geneva:WHO,1997:2-12 被引量:1
  • 4[7]Kim SJ.Drug resistant tuberculosis in Korea[J].Int J Tuberc Lung Dis,1997,1:302-308 被引量:1
  • 5Espinal MA,Laszlo A,Simonsen L,et al.Global trends in resistance to antituberculosis drugs.World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance[J].N Engl J Med,2001,344 (17):1294 -1303 被引量:1
  • 6Nachega JB,Chaisson RE.Tuberculosis drug resistance:a global threat[J].Clin Infect Dis,2003,36(Suppl 1):S24-30 被引量:1
  • 7Iseman MD.MDR-TB and the developing world-a problem no longer to be ignored:the WHO announces 'DOTS Plus' strategy[J].Int J Tuberc Lung Dis,1998,2(11):867 被引量:1
  • 8WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance.Anti-tuberculosis drug resistance in the world.Third report[J].WHO/HTM/TB/2004.343.Geneva:WHO,2004 被引量:1
  • 9Aziz MA,Wright A.The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance:a model for other infectious diseases[J].Clin Infect Dis,2005,41 Suppl 4:S258-262 被引量:1
  • 10屠德华.耐药性结核病的流行病学特征和意义[J].中华结核和呼吸杂志,1997,20(6):327-328. 被引量:103

共引文献255

同被引文献148

引证文献18

二级引证文献133

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部